Spanish medtech "cartel" cites market forces in its defence
This article was originally published in Clinica
Executive Summary
Pending confirmation of a prospective appeal by four companies recently found guilty of price-fixing in tenders for radiopharmaceutical products (see full story, published October 6), the judgement report provides an interesting insight into this market. Does the case in fact illustrate the market pressures faced by industry? observers will wonder.